Actively Recruiting
EARLY Intervention in Parent-professional Cooperation in Cerebral Palsy
Led by Hospices Civils de Lyon · Updated on 2026-04-24
66
Participants Needed
8
Research Sites
235 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Cerebral Palsy (CP) is the most common motor disability in children. It is due to damage that occurs during brain development in the fetus or infant. Early treatment (before 2 years) will allow the child to promote brain plasticity to compensate for the effects of the lesion and reduce the severity of CP. The goals of early intervention are to increase motor, cognitive and communication skills, prevent complications and provide parental support. Most authors agree to recognize the benefit of early care by emphasizing home intervention programs with active parental participation. To date, no recommendations exist in France for the management of cerebral palsy in children under the age of two. It is therefore necessary to conduct scientific studies in this population. Based on published international studies, the PRECOP program (PREcoce intervention in parent-professional COoperation in Cerebral Palsy) consists of individualized care adapted to the specific needs of each child, from the arrival of the infant at home, by a multidisciplinary team during the child's first two years.
CONDITIONS
Official Title
EARLY Intervention in Parent-professional Cooperation in Cerebral Palsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Newborn with brain lesions at high risk of cerebral palsy confirmed by ultrasound and MRI including stage 3 or 4 intraventricular hemorrhage, periventricular leukomalacia, perinatal anoxo-ischemic encephalopathy sequelae, or extensive neonatal stroke
- Less than 3 months old (corrected age if premature)
- Hospitalized in neonatology or pediatric intensive care unit, or within two months after returning home
- Affiliated with social security
- Parent or legal representative provides free and informed written consent
You will not qualify if you...
- Antenatal diagnosis of a pathology that could cause developmental delay
- Presence of a congenital pathology revealed at birth, including metabolic, genetic, or malformative origins
- Receiving palliative care with limitation or discontinuation of active treatments
- Currently participating in another screening and early care program (except the COCON program)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 8 locations
1
CH de Annecy
Annecy, France, 74370
Actively Recruiting
2
Service de Réanimation et médecine néonatale
Chambéry, France, 73011
Actively Recruiting
3
Service de Réanimation Néonatale, Hôpital de la Croix-Rousse, Hospices Civils de Lyon
Lyon, France, 69317
Actively Recruiting
4
Service de néonatologie et de réanimation néonatale, Hôpital Femme Mère Enfant, Hospices Civils de Lyon
Lyon, France, 69677
Actively Recruiting
5
Service de néonatologie et de réanimation néonatale, CHU Saint-ELOI
Montpellier, France, 34295
Actively Recruiting
6
Service de néonatologie et de réanimation néonatale, Hôpital Universitaire Carémeau
Nîmes, France, 30029
Actively Recruiting
7
Service de réanimation pédiatrique, Hôpital des enfants
Toulouse, France, 31059
Actively Recruiting
8
Service de néonatologie, Hôpital des enfants
Toulouse, France, 31300
Actively Recruiting
Research Team
V
Virginie MOURON, MD
CONTACT
J
Julie HAESEBAERT, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here